학술논문

A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC)
Document Type
Article
Source
In: Clinical Breast Cancer. (Clinical Breast Cancer, April 2022, 22(3):269-278)
Subject
Language
English
ISSN
19380666
15268209